SNANF

Healthcare Biotechnology

Sona Nanotech Inc.

$0.22

+0.00 +0.00% today

Price History

Not enough data

Key Stats

Market Cap

27.14M

Avg Volume

5,304

EPS

-$0.02

52W High

$0.59

52W Low

$0.19

Div. Yield

0.0%

Valuation

P/B Ratio

-50.85

EV/EBITDA

-15.19

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Growth & Returns

Return on Assets

(138.1%)

Liquidity & Leverage

Current Ratio

0.04

Quick Ratio

0.01

Total Cash

17,214

Total Debt

340,161

About

Sona Nanotech Inc. operates as a nanotechnology life sciences company in the United States and Canada The company researchers and develops gold nanoparticles for potential therapies, including photothermal therapy, tumor targeting activity, anti-bacterial activity, and drug delivery vehicle, as well as diagnostics, such as diagnostic markers for imaging and immunoassay and biosensing. It also engages in the development of targeted hyperthermia therapy, a photo thermal therapy for the treatment of cancer tumors; and diagnostic tools comprising lateral flow assay rapid and bovine tuberculosis tests. The company was founded in 2013 and is based in Halifax, Canada.